IRIS

SARACINO, ANNALISA

SARACINO, ANNALISA  

Dipartimento di Medicina Clinica e Sperimentale  

Mostra records
Risultati 1 - 20 di 82 (tempo di esecuzione: 0.019 secondi).
Titolo Data di pubblicazione Autore(i) File
"In vitro" spontaneous production of B-chemokines by endocervical and endometrial short-term bioptic cultures 1-gen-2001 Favia, A.; Di Stefano, Mariantonietta; M., Lepera; A., Mangiacotti; Saracino, Annalisa; Fiore, JOSE' RAMON; J. R., Angarano; G., Pastore
A Multidrug-Resistant (MDR) HIV Type 1 Infection in a Homosexual Man and Identified Source Patient 1-gen-2007 Monno, L.; Punzi, G.; Brindicci, G.; Lagioia, A.; Ladisa, N.; Saracino, Annalisa; Ingletti, M.; Angarano, G.
A Step Closer to the "Fourth 90": A Practical Narrative Review of Diagnosis and Management of Nutritional Issues of People Living with HIV 1-gen-2021 Bavaro, Davide Fiore; Laghetti, Paola; Poliseno, Mariacristina; De Gennaro, Nicolò; Di Gennaro, Francesco; Saracino, Annalisa
An outbreak of HIV-1 BC recombinants in Southern Italy 1-gen-2012 Monno, L.; Brindicci, G.; Lai, A.; Punzi, G.; Altamura, M.; Simonetti, F. R.; Ladisa, N.; Saracino, Annalisa; Balotta, C.; Angarano, G.
Antiretroviral genotypic resistance in plasma RNA and whole blood DNA in HIV-1 infected patients failing HAART 1-gen-2008 Saracino, Annalisa; Gianotti, N.; Marangi, M.; Cibelli, D. C.; Galli, A.; Punzi, G.; Monno, L.; Lazzarin, A.; Angarano, G.
Are the proposed env mutations actually associated with resistance to maraviroc? 1-gen-2010 Saracino, Annalisa; Monno, L.; Brindicci, G.; Trillo, G.; Altamura, M.; Punzi, G.; Lagioia, A.; Angarano, G.
Association between HLA class II antigens and hepatitis C virus infection 1-gen-2003 Scotto, G.; Fazio, V.; D'Allessandro, G.; Monno, L.; Saracino, Annalisa; Palumbo, E.; Angarano, G.
Autochtonous mucosal leishmaniasis in a hemodialyzed italian patient 1-gen-2002 Maggi, P.; Larocca, A. M. V.; Mininni, F.; Fiorentino, G.; Saracino, Annalisa; Chironna, M.; Quarto, M.
Both a protective and a deleterious role for the L76V mutation 1-gen-2009 Tartaglia, A. *; Saracino, Annalisa; Monno, L.; Tinelli, C.; Angarano, G.
Cervicovaginal HIV-1 shedding in pregnant women near delivery 1-gen-2001 Saracino, Annalisa; Di Stefano, Mariantonietta; M., Vimercati; Greco, Pantaleo; Fiore, JOSE' RAMON; J. R., Monno; L., Angarano; G., Pastore
Clinical and virological response to adefovir dipovixil for lamivudine-resistant HBeAg-negative hepatitis B 1-gen-2005 Scotto, G.; Palumbo, E.; Fazio, V.; Tartaglia, A.; Saracino, Annalisa; Angarano, G.
Clinical validation and applicability of different tipranavir/ritonavir genotypic scores in HIV-1 protease inhibitor-experienced patients 1-gen-2009 Saracino, Annalisa; Monno, L.; Tartaglia, A.; Tinelli, C.; Seminari, E.; Maggiolo, F.; Bonora, S.; Rusconi, S.; Micheli, V.; Lo, Caputo; S., Lazzaroni; L., Ferrara; S., Ladisa; N., Nasta; P., Parruti; G., Bellagamba; R., Forbici; F., Angarano
Co-receptor switch during HAART is independent of virological success 1-gen-2009 Saracino, Annalisa; Monno, L.; Cibelli, D. C.; Punzi, G.; Brindicci, G.; Ladisa, N.; Tartaglia, A.; Lagioia, A.; Angarano, G.
Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretrovirals therapies 1-gen-2003 Fiore, JOSE' RAMON; Suligoi, B.; Saracino, Annalisa; Di Stefano, Mariantonietta; M., Bugarini; R., Lepera; A., Favia; A., Monno; L., Angarano; G., Pastore
Decrease in Incidence Rate of Hospitalizations Due to AIDS-Defining Conditions but Not to Non-AIDS Conditions in PLWHIV on cART in 2008-2018 in Italy 1-gen-2021 Nozza, Silvia; Timelli, Laura; Saracino, Annalisa; Gianotti, Nicola; Lazzaretti, Claudia; Tavelli, Alessandro; Puoti, Massimo; Lo Caputo, Sergio; Antinori, Andrea; Monforte, Antonella d'Arminio; Mussini, Cristina; Girardi, Enrico; On Behalf Of Icona Foundation Study Group, Null
Detection of human herpesvirus 8 in cervicovaginal secretions and seroprevalence in human immunodeficiency virus type 1-seropositive and –seronegative women 1-gen-1999 Calabrò, M. L.; Fiore, JOSE' RAMON; Favero, A.; Lepera, A.; Saracino, Annalisa; Angarano, G.; Schulz, T. F.; Chieco, Bianchi
Difficulties in classifying a/g recombinants: methodological problems or genetic variability? 1-gen-2007 Brindicci, G.; Punzi, G.; Lagioia, A.; Lo, Caputo; S., Ladisa; Di, Nicuolo; Saracino, Annalisa; A., Angarano; G., Monno
Drug Resistance Mutations and Newly Recognized Treatment-Related Substitutions in the HIV-1 Protease Gene: Prevalence and Associations With Drug Exposure and Real or Virtual Phenotypic Resistance to Protease Inhibitors in Two Clinical Cohorts of Antiretroviral Experienced Patients 1-gen-2004 Torti, C.; Quiros, Roldan; E., Monno; L., Patroni; Saracino, Annalisa; A., Angarano; G., Tinelli; Lo, Caputo; S., Tirelli; V., Mazzotta; F., Carosi
Early and sustained virological response in non-responders with chronic hepatitis C: a randomized open-label study of pegylated interferon-alpha-2a versus pegylated interferon-alpha-2b 1-gen-2008 Scotto, G.; Fazio, V.; Fornabaio, C.; Tartaglia, A.; Di, Tullio; Saracino, Annalisa; A., Angarano
Efficacy and tolerability of lamivudine alone versus lamivudine plus alpha-interferon for treatment of chronic active hepatitis B in patients with a precore-mutant variant 1-gen-2006 Scotto, G.; Palumbo, E.; Fazio, V.; Cibelli, D. C.; Saracino, Annalisa; Angarano, C.